Table 2 Characteristics of human immunodeficiency virus (HIV) infected patients with chronic hepatitis C virus (HCV) at the time of liver biopsy according to sample length.
| Variable | Liver biopsy length | |
|---|---|---|
| All patients, ⩾10 mm (n = 357) | ⩾15 mm (n = 263) | |
| Age (y) | 37 (33–40) | 37 (34–41) |
| Males (n (%)) | 296 (83) | 220 (84) |
| Intravenous drug use or transfusion (n (%)) | 332 (93) | 241 (92) |
| Alcohol intake >50 g/day (n (%)) | 89 (25) | 77 (29) |
| Age at HCV infection* (y) | 21 (18–26) | 21 (17–25) |
| Duration of HCV infection* (y) | 15 (11–19) | 17 (12–19) |
| AST (UI/l) | 65 (44–103) | 5 (44–96) |
| ALT (UI/l) | 83 (55–132) | 80 (54–133) |
| GGT (UI/l) | 105 (56–186) | 106 (57–184) |
| Cholesterol (mg/dl) | 170 (144–194) | 170 (144–194) |
| Platelets (109/l) | 187 (146–224) | 186 (146–217) |
| International normalised ratio | 1.1 (1–1.3) | 1.1 (1–1.2) |
| Genotype 1† (n (%)) | 189 (53) | 134 (51) |
| HCV viral load‡ log10 (UI/ml) | 6.0 (5.7–6.4) | 5.95 (5.6–6.4) |
| Significant fibrosis (F2–F4) (n (%)) | 196 (55) | 153 (58) |
| Cirrhosis (n (%)) | 46 (13) | 40 (15) |
AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, γ‐glutamyl‐transpeptidase.
Not available in: (a) biopsy length ⩾10 mm: *32 patients; †36 patients; ‡31 patients; (b) biopsy length ⩾15 mm: *24 patients; †26 patients; ‡24 patients.